Get the app
NSE › Healthcare

Global Health Limited (MEDANTA)

NSE · Healthcare · Medical Care Facilities

₹1,387.60-0.15%
Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue
₹1,469 cr
Revenue YoY
+33.6%
Net profit
₹221 cr
Profit YoY
+39.3%
EPS
₹8.20
EPS estimate
₹6.90
Net margin
15.0%

EPS came in at 8.20 against a street estimate of 6.90 — a beat of 18.8%.

Key statistics

Market cap
₹37,321 cr
P/E
60.5
Forward P/E
0.0
P/B
8.99
Book value
₹160.85
EPS (TTM)
₹22.98
52-week high
₹1,544.00
52-week low
₹955.66
50-day MA
₹1,369.23
200-day MA
₹1,248.23
Beta
0.23

Analyst view

with an average price target of ₹1,592.74.

Shareholding

Promoters
33.00%
Institutions
26.92%

Largest named holders

HolderStake
Dunearn Investments (mauritius) Pte14.84%
Sunil Sachdeva10.04%
RJ Corp6.58%
Invesco India Business Cycle Fund5.17%
Kotak Contra Fund3.43%

Recent filings & reports

DocumentDate
Annual report FY2026
MEDANTA (GLOBAL HEALTH LIMITED) - FY 2025-26 SUMMARY HEADLINE NUMBERS • Revenue grew double-digit percentage across all quarters of FY 2025-26 • Int
2026-08-21
Q1 FY27 earnings call
MEDANTA (GLOBAL HEALTH LIMITED) - Q1 FY27 SUMMARY HEADLINE NUMBERS • Consolidated income: INR 13,262 million, up 26% year-on-year • Reported EBITDA
2026-08-05
Investor presentation
GLOBAL HEALTH LIMITED – Q1 FY2027 INVESTOR SUMMARY HEADLINE NUMBERS • Total Income: INR 13,262 million in Q1 FY27, up 26.2% year-on-year from INR 10
2026-07-30
Q4 FY26 earnings call
GLOBAL HEALTH LIMITED – MEDANTA Q4 FY26 EARNINGS SUMMARY --- HEADLINE NUMBERS • Total Income FY2026: INR 45,089 million, up 20% year-on-year • Tota
2026-05-20
Investor presentation · Q4 FY26
INVESTOR PRESENTATION SUMMARY: GLOBAL HEALTH LIMITED (MEDANTA) Q4 & FY2026 Results | May 14, 2026 --- HEADLINE NUMBERS • Total Income FY2026: INR 4
2026-05-14
Quarterly results · Q4 FY26
GLOBAL HEALTH LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Full Year Revenue (FY2026): ₹37,093.78 million (up 15.8% from ₹32,041.46 million in FY2
2026-05-14
Q3 FY26 earnings call
GLOBAL HEALTH LIMITED (MEDANTA) – Q3 FY26 SUMMARY HEADLINE NUMBERS • Total income Q3 FY26: Rs.11,428 million, up 19% year-on-year • EBITDA (excludin
2026-02-09
Quarterly results · Q3 FY26
GLOBAL HEALTH LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS Q3 FY2026 (Quarter ended 31 December 2025) – STANDALONE • Revenue from operations: ₹9,401
2026-02-04

Readable in the app.

Corporate actions

ActionDetailDate
Dividend₹0.50 / share
ex-date Aug 14, 2026
2026-08-14

Deals & corporate news

AnnouncementDate
Capacity addition announced
Global Health Limited has informed the Exchange about Capacity addition
2026-11-03
Acquisition of land parcel for healthcare facility expansion in Ghaziabad
Medanta (Global Health Limited) announced the acquisition of a 10,560 square metre land parcel in Ghaziabad, Uttar Pradesh for ₹165.82 crore through an online auction by the Uttar Pradesh Ho
2026-09-29
Capacity addition announced for production expansion
Global Health Limited has informed the Exchange about Capacity addition
2026-07-30
Capacity addition announced for production expansion
Global Health Limited has informed the Exchange about Capacity addition
2026-04-27
Capacity addition announced by the company
Global Health Limited has informed the Exchange about Capacity addition
2026-03-25

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Global Health Limited — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-11-07.